 |
 |
 |
|||||||||||
|
|
"Improving Nature"QuantiBact is developing a technology that will significantly improve molecular diagnostics in the near future.
QuantiBact A/S is a biotech company founded on research regarding nucleic acid analogues performed at Syddansk Universitet and Hvidovre Hospital. We are developing diagnostic tools for the detection of infectious diseases by: increasing specificity, minimizing turn-around time and increasing fidelity of quantification. Our technology will significantly improve hybridization and PCR based assays. |
 |
|
|||||||||
 |
|
||||||||||||
 |
|
||||||||||||
 |
 |
|
|||||||||||
 |
 |
 |
|
||||||||||
|
|
|
|
|
|
|
|
|||||||